PRO MEDICUS LIMITED — Director's Dealing 2020

Mar 17, 2020

Appendix 3Y Change of Director’s Interest Notice

Listing Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Pro Medicus Limited ABN 25 006 194 752

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Leigh FARRELL
Date of last notice	26 November 2019

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	Ordinary fully paid shares in Pro MedicusLimited held by the L&L Farrell Family TrustPty Ltd of which the Director is a Trustee andMember
Date of change	17 March 2020
No. of securities held prior to change	3,241 ordinary shares
Class	Ordinary shares
Number acquired	999
Number disposed	Nil
Value/ConsiderationNote: If consideration is non-cash, provide details and estimated valuation	$15.48 per share
No. of securities held after change	4,240 ordinary shares
Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	On market purchase

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

art 2 – Change ofote: In the case of a company, in	director’s interests in contractsterests which come within paragraph (ii) of the definition of “notifi		able interest of a director” should be
sclosed in this part.
Detail of contract		N/A
Nature of interest		N/A
Name of registere(if issued securitie	d holders)	N/A
Date of change		N/A
No. and class of se	curities to which	N/A
interest related prNote: Details are only requireto which the interest has chan	ior to changed for a contract in relationged
Interest acquired		N/A
Interest disposed		N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation		N/A
Interest after change		N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed	No
above traded during a+closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the	N/A
trade to proceed during this period?
If prior written clearance was provided, on what date was	N/A
this provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

For and on behalf of Pro Medicus Limited

==> picture [133 x 63] intentionally omitted <==

Clayton Hatch Company Secretary 18 March 2020

• See chapter 19 for defined terms.

Appendix 3Y Page 3

11/3/2002